Santen Pharmaceutical Co., Ltd.

Oculeve, Inc.

Becton Dickinson and Company Limited

Hubbell Limited

Daniel N Hamilton

Anand Doraiswamy

Jensen Buck

James Donald Loudin

Manfred Franke

Douglas Michael Ackermann

John L Wardle

James J Kennedy, Iii

Janusz Kuzma

Jude Cancellieri

Jarren Armond Baldwin

Austin Jason McKinnon

Laurie G Sanders

Richard Mann

Yan Yevmenenko

Kelly Suzanne Hawkins

Jacob C Atchley

Christopher William Stivers

Lai Chiu Tang

Paul Paia Marici

Douglas Michael Ackermann, Jr

Derek Hugger

Diane Michelle Senchyna

Kivilcim Eralp

Austin Mckinnon

James J Kennedy

James J Iii Kennedy

Iii James J Kennedy

An assembly fixture device for attaching a vial adapter to a vial includes a base, a support member secured to the base, a handle connected to the support member, a vial adapter grip assembly connected to the handle and comprising an adapter grip member configured to engage and hold a vial adapter, and a vial grip assembly connected to the base comprising first and second grip members that are movable relative to each other and configured to engage and hold a vial. The first grip member is biased toward the second grip member to provide a vial engagement force, where the vial engagement force is about constant when a distance between the first and second grip members is less than 40 mm.

Assembly fixture device for attachment of vial adapter to drug vial

Described here are devices, systems, and methods for treating one or more conditions, such as allergic rhinitis, non-allergic rhinitis, nasal congestion, ocular allergy, and/or symptoms associated with these conditions, by providing stimulation to nasal or sinus tissue. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs, and the nasal insertion prongs may be configured to deliver an electrical stimulus to the tissue.

Nasal stimulation for rhinitis, nasal congestion, and ocular allergies

A connection apparatus for a medical device includes a first connection member having a first end and a second end with the first connection member defining at least one channel adjacent the first end. The at least one channel having a first portion extending in an axial direction and a shoulder adjacent to the first end of the first connection member that defines a channel entry. The at least one channel having a second portion extending in a transverse direction relative to the axial direction. The connection apparatus further including a second connection member having a first end and a second end and at least one protrusion adjacent the first end. The shoulder is configured to guide the at least one protrusion of the second connection member into the channel entry regardless of the orientation of the at least one protrusion relative to the channel entry.

Connection apparatus for a medical device

Described here are devices, systems, and methods for treating meibomian gland disease and/or blepharitis by providing intranasal stimulation. Generally, the devices may deliver electrical stimulation to the nasal mucosa. Intranasal stimulation may unblock obstructed meibomian glands and increase the lipid content of tears, both acutely during stimulation and subsequent to intranasal stimulation. The methods may include an initial round of stimulation to unblock obstructed meibomian glands, and subsequent shorter rounds of stimulation to cause meibum secretion and maintain the open glands.

Intranasal stimulation for treatment of meibomian gland disease and blepharitis

Described here are devices, systems, and methods for increasing tear production by stimulating the cornea, conjunctiva, and/or subconjunctiva. In some variations, the devices may be in the form of a contact lens. The contact lens may comprise a lens body and a stimulator chip, where the stimulator chip is embedded in the lens body. An external power source wirelessly transmits energy to the stimulator chip, where the stimulator chip may convert the energy to an electric waveform to stimulate the cornea, conjunctiva, and/or subconjunctiva. Stimulation may activate the lacrimal reflex to increase tear production. The devices and systems for increasing tear production may be used in methods of treating dry eye, reducing the symptoms of tired eye, increasing comfort for contact lens wearers, and extending the number of years a contact lens user can wear contacts. Also described are methods of manufacturing a contact lens.

Implantable device for increasing tear production

Contact lens for increasing tear production

Described here are devices, systems, and methods for treating one or more conditions (such as dry eye) or improving ocular health by providing stimulation to nasal or sinus tissue. Generally, the devices may be handheld or implantable. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs. When the devices and systems are used to treat dry eye, nasal or sinus tissue may be stimulated to increase tear production, reduce the symptoms of dry eye, and/or improve ocular surface health.

Nasal stimulation devices and methods

Intraocular lens

An intraocular lens comprises an optic and at least two haptics, each of which comprises a step feature that protrudes from a posterior surface of the haptic to prevent posterior capsular opacification.

Growing community of inventors

Napa, CA, United States of America

Daniel N Hamilton